Skip to Main Content

Updated NETs Clinical Trials

Studies found on ClinicalTrials.gov by a search of: Other terms: neuroendocrine NOT Melanoma NOT PMS | Last update posted in the last 30 days
  1. Conditions: Neuroendocrine Neoplasm; China; Women; Cervical Cancer; Cervical Lesion Sponsors: Fujian Maternity and Child Health Hospital Recruiting
  2. Conditions: Autoimmune Gastritis Interventions: Other: oral administration of a compound digestive enzyme capsule; Other: oral administration of apple cider vinegar; Other: oral administration of both the compound digestive enzyme capsule and apple cider vinegar Sponsors: Jianning Yao Not yet recruiting
  3. Conditions: Gastrointestinal Cancer; Colon Cancer; Rectal Cancer; Anal Cancer; Esophageal Cancer; Stomach Cancer; Appendix Cancer; Pancreas Cancer; Liver Cancer; Neuroendocrine Tumors Interventions: Other: EQUITY GI Sponsors: Case Comprehensive Cancer Center Not yet recruiting
  4. Conditions: Post-operative Pain Interventions: Other: Communication between nursing staff and participants Sponsors: University of Haifa Recruiting
  5. Conditions: Gastroenteropancreatic Neuroendocrine Tumor; Radiotherapy Interventions: Other: Simultaneous 68Ga-DOTATOC PET-MRI Sponsors: Assistance Publique - Hôpitaux de Paris Not yet recruiting
  6. Conditions: Gastro-enteropancreatic Neuroendocrine Tumor; Acromegaly Sponsors: Ipsen Not yet recruiting
  7. Conditions: Depressive Symptoms; Human-Animal Interaction Interventions: Drug: Oxytocin nasal spray; Other: Animal-Assisted Intervention; Drug: Placebo Sponsors: Dr. Karin Hediger Not yet recruiting
  8. Conditions: Advanced Pancreatic Neuroendocrine Tumor Interventions: Other: Chemotherapy and targeted-therapy guided by organoid drug sensitivity test Sponsors: Ruijin Hospital; Chongqing Kingbiotech Co.,Ltd Not yet recruiting
  9. Conditions: Medullary Thyroid Cancer; Medullary Carcinoma; Medullary Tumor; Medullary Neoplasms; Desmoplasia; Desmoplastic; Desmoplastic Reaction; Lymph Node Metastasis; Lymph Node Disease Sponsors: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Completed
  10. Conditions: Pain Management Interventions: Procedure: Group M-TAPA; Procedure: Group Serratus Intercostal Plane Block and Rectus Sheath Block Sponsors: Hitit University Recruiting
  11. Conditions: Neuroendocrine Neoplasms Interventions: Drug: [68Ga]Ga-DOTA-TATE; Drug: 68Ge/68Ga Generator Sponsors: Novartis Pharmaceuticals; Eckert & Ziegler Radiopharma GmbH Not yet recruiting
  12. Conditions: Prostate Cancer; Prostatic Hyperplasia; Prostatic Neoplasms; Prostate Cancer Metastatic; Neuroendocrine Tumors; Neuroendocrine Carcinoma Interventions: Diagnostic Test: J-PET scan Sponsors: Jagiellonian University; University Hospital in Krakow Not yet recruiting
  13. Conditions: Neuroblastoma; Pheochromocytoma; Paraganglioma Interventions: Drug: 18F-mFBG Sponsors: Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC); Albert Einstein College of Medicine Not yet recruiting
  14. Conditions: Neuroendocrine Tumors Interventions: Combination Product: Pembrolizumab in combination with carboplatin and etoposide chemotherapy followed by pembrolizumab and lenvatinib maintenance therapy Sponsors: Imperial College London Not yet recruiting
  15. Conditions: Functional Disorder Interventions: Behavioral: Patient Education; Drug: Duloxetine; Drug: Benztropine Mesylate 0.5 MG and passive placebo RAP; Behavioral: Enhanced usual care Sponsors: Aarhus University Hospital; Central Denmark Region; University of Aarhus; Vejle Hospital; Aalborg University Hospital; TrygFonden, Denmark; Independent Research Fund Denmark Recruiting
  16. Conditions: Adrenal Tumor; Primary Aldosteronism; Cushing Syndrome; Pheochromocytoma; Adrenal Cortical Carcinoma Sponsors: Seoul National University Hospital; Asan Medical Center; Seoul National University Bundang Hospital; Samsung Medical Center; Inha University Hospital; Chonnam National University Hospital; Nowon Eulji Medical Center Recruiting
  17. Conditions: Small Cell Carcinoma of the Bladder; High Grade Neuroendocrine Tumors of the Urinary Tract Interventions: Drug: Lurbinectedin; Drug: Avelumab Sponsors: National Cancer Institute (NCI) Not yet recruiting
  18. Conditions: Attention Deficit and Hyperactivity Disorders Interventions: Dietary Supplement: multiple-strain probiotics Sponsors: Tsyr-Huey Mental Hospital Recruiting
  19. Conditions: Digestive System Neuroendocrine Neoplasm; Lung Neuroendocrine Neoplasm; Malignant Solid Neoplasm; Pancreatic Neuroendocrine Neoplasm Interventions: Procedure: Biospecimen Collection; Procedure: Computed Tomography; Biological: Incomplete Freund''s Adjuvant; Procedure: Magnetic Resonance Imaging; Biological: Sargramostim; Biological: SVN53-67/M57-KLH Peptide Vaccine; Drug: Temozolomide Sponsors: Roswell Park Cancer Institute Not yet recruiting
  20. Conditions: Metastatic Chondrosarcoma; Locally Advanced Chondrosarcoma; Metastatic Sinonasal Adenocarcinoma; Locally Advanced Sinonasal Adenocarcinoma; Metastatic Large-cell Neuroendocrine Carcinoma; Locally Advanced Large-cell Neuroendocrine Carcinoma; Metastatic Olfactory Neuroblastoma; Locally Advanced Olfactory Neuroblastoma; Metastatic Sinonasal Undifferentiated Carcinoma; Locally Advanced Sinonasal Undifferentiated Carcinoma Interventions: Drug: Enasidenib Sponsors: National Cancer Institute (NCI) Recruiting
  21. Conditions: Small Cell Carcinoma of the Bladder; Small Cell Carcinoma of the Urinary Tract; Squamous Cell Carcinoma of the Bladder; Squamous Cell Carcinoma of the Urinary Tract; Primary Adenocarcinoma of the Bladder; Primary Adenocarcinoma of the Urinary Tract; Renal Medullary Carcinoma; Squamous Cell Carcinoma of the Penis Interventions: Drug: Sacituzumab govitecan; Drug: Atezolizumab Sponsors: National Cancer Institute (NCI) Not yet recruiting
  22. Conditions: Adrenal Cortical Carcinoma; Medullary Thyroid Cancer; Thymic Neuroendocrine Carcinoma; Pancreatic Neuroendocrine Tumor Interventions: Biological: individualized mRNA neoantigen vaccine (mRNA-0523-L001) Sponsors: Shanghai Jiao Tong University School of Medicine Recruiting
  23. Conditions: Neuroendocrine Neoplasms Interventions: Drug: BI 764532; Drug: Carboplatin; Drug: Etoposide; Drug: Cisplatin Sponsors: Boehringer Ingelheim Recruiting
  24. Conditions: Metastatic Neuroendocrine Tumour Sponsors: Hospices Civils de Lyon Active, not recruiting
  25. Conditions: Neuroendocrine Carcinomas; Neuroendocrine Tumors; Carcinoma, Neuroendocrine; Carcinoma, Adrenocortical; Carcinoma, Adrenal Cortical Interventions: Drug: ADCT-701 Sponsors: National Cancer Institute (NCI) Not yet recruiting
  26. Conditions: Neuroendocrine Tumors; NET; Pancreatic Neuroendocrine Tumor; Gastrointestinal Neuroendocrine Tumor; Pulmonary Neuroendocrine Tumor Interventions: Drug: nab-sirolimus Sponsors: Aadi Bioscience, Inc. Recruiting
  27. Conditions: Major Depression Interventions: Procedure: Repetitive transcranial magnetic stimulation (rTMS) Sponsors: Centre Hospitalier Rouffach Recruiting
  28. Conditions: Small Cell Lung Carcinoma (SCLC); Neuroendocrine Neoplasms Interventions: Drug: BI 764532; Drug: [89Zr]Zr-BI 764532 Sponsors: Boehringer Ingelheim Not yet recruiting
  29. Conditions: Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8; Clinical Stage IV Cutaneous Merkel Cell Carcinoma AJCC v8; Locally Advanced Merkel Cell Carcinoma; Metastatic Merkel Cell Carcinoma; Refractory Merkel Cell Carcinoma; Unresectable Merkel Cell Carcinoma Interventions: Drug: Avelumab; Procedure: Biopsy; Procedure: Biospecimen Collection; Procedure: Computed Tomography; Procedure: Magnetic Resonance Imaging; Procedure: Positron Emission Tomography; Drug: Tuvusertib Sponsors: National Cancer Institute (NCI) Recruiting
  30. Conditions: Neuroendocrine Tumors Sponsors: Ipsen Terminated
  31. Conditions: Small Cell Lung Carcinoma; Neuroendocrine Neoplasms Interventions: Drug: BI 764532 Sponsors: Boehringer Ingelheim Recruiting
  32. Conditions: Small Cell Lung Carcinoma (SCLC); Neuroendocrine Neoplasms Interventions: Drug: BI 764532; Drug: Ezabenlimab Sponsors: Boehringer Ingelheim Recruiting
  33. Conditions: Somatostatin Receptor-positive Neuroendocrine Tumor Interventions: Other: LUTATHERA Sponsors: Novartis Pharmaceuticals Recruiting
  34. Conditions: Hepatocarcinoma; Pancreatic Tumor Interventions: Biological: Hepatocellular carcinoma; Biological: Pancreatic adenocarcinoma; Biological: Pancreatic neuroendocrine tumor Sponsors: Assistance Publique - Hôpitaux de Paris Recruiting
  35. Conditions: Metastatic Midgut Neuroendocrine Tumor; Metastatic Midgut Neuroendocrine Tumor G1; Metastatic Midgut Neuroendocrine Tumor G2; Unresectable Midgut Neuroendocrine Tumor Interventions: Procedure: Biospecimen Collection; Procedure: Computed Tomography; Drug: Everolimus; Drug: Lutetium Lu 177 Dotatate; Other: Quality-of-Life Assessment; Other: Questionnaire Administration Sponsors: National Cancer Institute (NCI) Recruiting
  36. Conditions: Metastatic Neuroendocrine Tumor Interventions: Procedure: Biospecimen Collection; Procedure: Computed Tomography; Drug: Lutetium Lu 177 Dotatate; Procedure: Magnetic Resonance Imaging; Drug: Triapine Sponsors: National Cancer Institute (NCI) Recruiting
  37. Conditions: Colorectal Neuroendocrine Carcinomas (CRNEC); Genomic Landscape; Genetic Landscape; Prognosis; CCL5; PAX5 Sponsors: Zhejiang University Completed
  38. Conditions: Vestibular Schwannoma Interventions: Procedure: Microsurgical resection of VS; Radiation: Stereotactic radiosurgery; Other: PREHAB Sponsors: Medical College of Wisconsin Recruiting
  39. Conditions: Metastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation; Metastatic Prostate Neuroendocrine Carcinoma; Metastatic Prostate Small Cell Neuroendocrine Carcinoma; Stage IV Prostate Cancer AJCC v8 Interventions: Procedure: Biospecimen Collection; Procedure: Computed Tomography; Drug: Lutetium Lu 177 Dotatate; Procedure: Positron Emission Tomography Sponsors: National Cancer Institute (NCI) Recruiting
  40. Conditions: Alcohol Use Disorder Interventions: Behavioral: Sleep extension and advance; Behavioral: Regular sleep duration and timing Sponsors: University of Oregon; University of Pittsburgh; National Institute on Alcohol Abuse and Alcoholism (NIAAA) Recruiting
  41. Conditions: Small Cell Lung Cancer Extensive Stage; Large Cell Neuroendocrine Carcinoma of the Lung Interventions: Biological: LB2102 Sponsors: Legend Biotech USA Inc Recruiting
  42. Conditions: RET-altered Non Small Cell Lung Cancer; Medullary Thyroid Cancer; RET-altered Papillary Thyroid Cancer; Neoplasms Interventions: Drug: TY-1091 Sponsors: TYK Medicines, Inc Recruiting
  43. Conditions: Small Cell Lung Cancer (SCLC); Large Cell Neuroendocrine Cancer (LCNEC); Neuroendocrine Prostate Cancer (NEPC); Gastroenteropancreatic Neuroendocrine Carcinoma (GEP-NEC) Interventions: Drug: PT217 Sponsors: Phanes Therapeutics Recruiting
  44. Conditions: Small Cell Lung Cancer; Neuroendocrine Carcinoma Interventions: Drug: RO7616789; Drug: Tocilizumab Sponsors: Hoffmann-La Roche Recruiting
  45. Conditions: Pancreatic Neuroendocrine Tumor; Pancreas Cancer Interventions: Procedure: cytoreductive surgery; Drug: Lutathera - a small molecule used in Peptide Receptor Radionuclide Therapy (PRRT); Procedure: Peptide receptor radionuclide therapy (PRRT) Sponsors: University of Chicago Recruiting
  46. Conditions: Advanced Solid Tumors Interventions: Drug: ABBV-706; Drug: Cisplatin; Drug: Budigalimab; Drug: Carboplatin Sponsors: AbbVie Recruiting
  47. Conditions: Acute Peripheral Vestibulopathy Following Surgical Procedure Interventions: Procedure: Prehabituation; Procedure: 3D optokinetic stimulation in virtual reality space; Procedure: Vestibular training Sponsors: Charles University, Czech Republic Recruiting
  48. Conditions: Intracranial Glioma; Metastatic Brain Tumor; Breast Cancer; Neuroendocrine Tumors; Rectal Cancer Interventions: Drug: 1-(2-[18F]FLUOROETHYL)-L-Tryptophan Sponsors: Barbara Ann Karmanos Cancer Institute; Washington University School of Medicine Recruiting
  49. Conditions: Stress; Stress, Psychological; Stress, Physiological; Anxiety; Mental Well Being; Happiness; Resilience Interventions: Behavioral: SKY Sponsors: University of Alabama at Birmingham; M.D. Anderson Cancer Center Recruiting
  50. Conditions: Stage I Testicular Seminoma; Stage I Testicular Nonseminomatous Germ Cell Tumor; Gastrointestinal Stromal Tumors; Ovarian Germ Cell Tumor; Adenocarcinoma, Clear Cell; Borderline Ovarian Tumor; Sex Cord-Stromal Tumor; Mucinous Adenocarcinoma of Ovary; Carcinoma, Small Cell; Carcinosarcoma, Ovarian; Serous Tumor of Ovary; Glioma; Neuroendocrine Tumors; Aggressive Fibromatosis of Abdominal Wall (Disorder) Interventions: Other: Oncological Follow-up Sponsors: Centre Oscar Lambret; Canceropôle Nord Ouest; Groupement Interrégional de Recherche Clinique et d'Innovation Recruiting